Ercanetide (NNZ 2591) is a synthetic analogue of a small peptide of cyclic glycine proline (cGP). Ercanetide shows orally active and cross the blood-brain barrier. Ercanetide shows neuroprotective after ischemic brain injury. NNZ 2591 improves motor function in a rat model of Parkinsons disease. Ercanetide has the potential for the research of ischemic brain injury and angelman syndrome[1][2][3].
Molecular Weight:
194.23
Purity:
99.98
CAS Number:
[847952-38-9]
Formula:
C10H14N2O2
Target:
Biochemical Assay Reagents
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted